PPIs for GERD Reduce COPD Exacerbation Risk in Post-Treatment Period
Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD.
Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD.
Researchers investigated the relationship between starting biologic treatment early for Crohn disease and health care costs.
Researchers sought to present the incidence and prevalence of inflammatory bowel diseases over 4 decades.
Research on the effect of NSAID use, including aspirin, on bone health, has resulted in conflicting results.
The tools used in an adolescent transition program to aide patients with HIV infection transition to independent care were evaluated for effectiveness.
Researchers analyzed the outcomes of laparoscopic liver resection of intrahepatic cholangiocarcinoma.
Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
Researchers examined pain medication usage trends before and after initiating advanced therapy in patients newly diagnosed with inflammatory bowel disease.
Researchers assessed the effect of tapering of corticosteroids or immunosuppressive therapy on disease activity, flare rate, and remission among patients with stable systemic lupus erythematosus.
Researchers assessed the risks and benefits of glucocorticoids in women with inflammatory rheumatic musculoskeletal diseases.